Evidence map›Paper›PMID 26324155›Full record

ArticleAge (Dordrecht, Netherlands)2015

Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cells.

Ulrik Stervbo, Sarah Meier, Julia Nora Mälzer, Udo Baron, Cecilia Bozzetti, Karsten Jürchott, Mikalai Nienen, Sven Olek, Dominika Rachwalik, Axel Ronald Schulz and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Age (Dordrecht, Netherlands), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Biomarkers of ageing of humans and non-human primates.Nature reviews. Molecular cell biology · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biomarkers of aging.Science China. Life sciences · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Immune ageing at single-cell resolution.Nature reviews. Immunology · 2022
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Ulrik StervboBerlin-Brandenburg Center for Regenerative Therapies, Charité - University Medicine, Föhrer Str. 15, 13353, Berlin, Germany.
Sarah Meier
Julia Nora Mälzer
Udo Baron
Cecilia Bozzetti
Karsten Jürchott
Mikalai Nienen
Sven Olek
Dominika Rachwalik
Axel Ronald Schulz
Julian Marcel Waldner
Avidan Neumann
Nina Babel
Andreas Grützkau
Andreas Thiel
Berlin-Brandenburger Centrum für Regenerative Therapien · DEUniversitätsklinik Marien Hospital Herne · DELeibniz Association · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosenescence is a hallmark of the aging immune system, leading to increased susceptibility to infections in the aged population and decreased ability to eradicate infectious pathogens. These effects, in turn, result in an increased burden on the healthcare system due to elevated frequency and duration of hospital visits. Growing evidence suggests that cells of the innate immune system are central modulators for the initiation and maintenance of an adequate pathogen-specific response through the adaptive immune system. While there are many reports on age-dependent alterations and dysfunctions of the adaptive immune system, the underlying mechanisms and effects of natural aging on the composition of the innate immune system remain unknown. Here, we present the results obtained from the comprehensive immunophenotyping of innate leukocyte populations, examined for age-related alterations within different sub-populations assessed using multi-parametric flow cytometry. We compared peripheral blood mononuclear cells from 24 young (aged 19-30 years) and 26 elderly (aged 53-67 years) donors. For classical CD16(+)CD56(dim) NK cells, the fraction of CD62L(+)CD57(+) was diminished in the elderly donors compared with young individuals, while the other investigated NK subsets remained unaffected by age. Both transitional monocytes and non-classical CD14(+-)CD16(++) monocytes were increased in the elderly compared with the young. The populations of pDCs and mDC2 were decreased among the elderly. These data demonstrate that the dynamics of the mDC subsets might counteract decreased virus surveillance. Furthermore, these data show that the maturation of NK cells might gradually slow down.

Indexed as

Immunity, InnateAdultAgedAgingDendritic CellsFemaleFlow CytometryFollow-Up StudiesHumansImmunophenotypingKiller Cells, NaturalLeukocytesMaleMiddle AgedRetrospective StudiesYoung Adult

Identifiers

PMID26324155
PMCPMC5005831
OpenAlexW1249753256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.